title: Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids.
abstract: Studies that have shown adverse effects of trans-unsaturated fatty acids on plasma lipoprotein (a) [Lp(a)] levels have used levels of trans-fatty acid that are higher than those in the average U.S. diet. This study was conducted to clarify the effects on Lp(a) of trans-fatty acids levels commonly found in U.S. diets. Lp(a) levels were measured in a double-blind study of 29 men and 29 women who ate 4 controlled diets in random order for 6 weeks each. Fatty acids represented 39% to 40% of energy. The diets were: (1) Oleic (16.7% of energy as oleic acid); (2) Moderate trans (3.8% of energy as trans-monoenes, approximately the trans content of the U.S. diet); (3) High trans (6.6% of energy as trans-monoenes); (4) Saturated (16.2% of energy as lauric plus myristic plus palmitic acids). The Saturated diet lowered Lp(a) levels significantly (by 8% to 11%). Compared to the Oleic diet, the trans diets had no adverse effect on Lp(a) levels when all subjects were considered collectively. A subset with initially high levels of Lp(a) (> or = 30 mg/dL), however, responded to the High trans diet with a slight (5%) increase in Lp(a) levels relative to the Oleic and Moderate trans diets. Thus, in amounts commonly found in the typical U.S. diet, saturated fatty acids consistently decrease Lp(a) concentrations. The adverse effects of replacing cis- with trans-fatty acids are only suggestive and are restricted to high trans intakes in subjects with high Lp(a) levels.
authors.affiliation: Diet and Human Performance Laboratory, Beltsville Human Nutrition Research Center, USDA, MD 20705-2350, USA. Bev@bhnrc.arsusda.gov
authors.forename: B A
authors.initials: BA
authors.lastname: Clevidence
authors.forename: J T
authors.initials: JT
authors.lastname: Judd
authors.forename: E J
authors.initials: EJ
authors.lastname: Schaefer
authors.forename: J L
authors.initials: JL
authors.lastname: Jenner
authors.forename: A H
authors.initials: AH
authors.lastname: Lichtenstein
authors.forename: R A
authors.initials: RA
authors.lastname: Muesing
authors.forename: J
authors.initials: J
authors.lastname: Wittes
authors.forename: M E
authors.initials: ME
authors.lastname: Sunkin
mesh_terms: D000328:Adult; D000368:Aged; D004041:Dietary Fats / Q000008:administration & dosage* / Q000494:pharmacology; D005227:Fatty Acids / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D013237:Stereoisomerism
chemical_list: D004041:Dietary Fats; D005227:Fatty Acids; D017270:Lipoprotein(a); D008074:Lipoproteins